# Cost-utility and Biological Underpinnings of MBSR in Fibromyalgia Syndrome

> **NCT02561416** · PHASE3 · COMPLETED · sponsor: **Fundació Sant Joan de Déu** · enrollment: 225 (actual)

## Conditions studied

- Fibromyalgia Syndrome

## Interventions

- **BEHAVIORAL:** MBSR
- **BEHAVIORAL:** FibroQol
- **DRUG:** TAU

## Key facts

- **NCT ID:** NCT02561416
- **Lead sponsor:** Fundació Sant Joan de Déu
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-01
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2019-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561416, "Cost-utility and Biological Underpinnings of MBSR in Fibromyalgia Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02561416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*